Expediting R&D Digitization for Life Sciences, ArisGlobal Introduces LifeSphere® NavaX™ – The Next-Generation Cognitive Computing Engine
NavaX will revolutionize the end-to-end Research and Development processes with ...
NavaX will revolutionize the end-to-end Research and Development processes with ...
Michael Gordon steps down as CEO, assumes role within Nordic ...
Boston, Massachusetts, USA – November 8, 2023 – ArisGlobal, creator ...
"This investment is a reflection of our dedication to our ...
Pharmaceutical company intends to digitize safety processes with LifeSphere Safety’s ...
Move reflects the growth needs and geographically positions the life ...
Executive additions and operational enhancements support the company’s significant growth ...
The acquisition enhances ArisGlobal LifeSphere Regulatory solutions with robust data ...
Information industry veteran Julie Springer joins Aris Global as first ...
The deal introduces Quality Management functionalities into LifeSphere’s product ecosystem, ...
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 500 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved